Integrating Tobacco use cessation into HIV Care and Treatment Clinics in Ministry of Health Facilities in Kisumu County, Kenya.

niversity of California San Francisco0 个研究点目标入组 580 人开始时间: 2022年11月18日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Clinical Component (Randomized Control trial):
•-age =18 years
•-HIV-seropositive
•-on or initiating ART
•-not planning to move or travel within 12 weeks following entry in the study
•-Tobacco inclusion criteria: current tobacco users, i.e. used tobacco in the past 7 days; for smokers, smoked at least 100 cigarettes in lifetime, and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO)= 5-6 parts per million (ppm).
•-access to mobile phone for phone contact (and on intensive intervention also for text follow up visit)
•Additional inclusion criteria for intensive intervention only:
•-able to read or be read for the SMS messages

•Clinical Component:
•-age < 18 years
•-HIV-seronegative
•-unable to provide informed consent
•-unwilling to be contacted by clinic for follow up
•-Opioid users (who may be receiving Bupropion as part of their treatment)
•Additional exclusion criteria for intensive intervention only:
•-Myocardial Infarction in the 2 weeks prior to enrolling in the study
•-Pregnant (as NRT and Bupropion might be contraindicated).
•-We will also exclude patients for whom Bupropion is contraindicated (e.g. history of seizures, recent use of MAO inhibitors, breastfeeding, and whose ART protocol present, as per prescription guidance, contraindications).
•-For those who share phones, prior disclosure of HIV status to the phone owner will be required to prevent inadvertent disclosure

发起方

niversity of California San Francisco